Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy

Molecular Therapy

Volumn 15, Issue 5, 2007, Pages 921-929

  Mocanu, Joseph D ^a,b   Yip, Kenneth W ^a,b   Alajez, Nehad M ^a,b   Shi, Wei ^a,b   Li, Jian Hua ^a,b   Lunt, Sarah J ^a,b   Moriyama, Eduardo H ^a,b   Wilson, Brian C ^a,b   Milosevic, Michael ^a,b   Lo, Kwok Wai ^c   van Rooijen, Nico ^d   Busson, Pierre ^e   Bastianutto, Carlo ^a,b   Liu, Fei Fei ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CLODRONIC ACID; E1A PROTEIN; IMATINIB; LIPOSOME; LUCIFERASE; NORADRENALIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER GENE THERAPY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; LIVER; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCID MOUSE; SURVIVAL TIME; TISSUE DISTRIBUTION; TISSUE PRESSURE; TISSUE SPECIFICITY; TUMOR; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CLODRONIC ACID; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; LIVER; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; NEOPLASMS; PHOSPHORYLATION; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TISSUE DISTRIBUTION;

ADENOVIRIDAE; HUMAN HERPESVIRUS 4; MUS;

EID: 34247199357     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.sj.6300119     Document Type: Article

References (50)

1. Li, JH, Chia, M, Shi, W, Ngo, D, Strathdee, CA, Huang, D et al. (2002). Tumor-targeted gene therapy far nasopharyngeal carcinoma. Cancer Res 62: 171-178.
2. Li, JH, Shi, W, Chia, M, Sanchez-Sweatman, O, Siatskas, C, Huang, D et al. (2003). Efficacy of targeted FasL in nasopharyngeal carcinoma. Mol Ther 8: 964-973.
3. Yip, KW, Li, A, Li, JH, Shi, W, Chia, MC, Rashid, SA et al. (2004). Potential utility of BimS as a novel apoptotic therapeutic molecule. Mol Ther 10: 533-544.
4. Chia, MC, Shi, W, Li, JH, Sanchez, O, Strathdee, CA, Huang, D et al. (2004). A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy. Mol Ther 9: 804-817.
5. Wisse, E, Van Dierendonck, JH, De Zanger, RB, Fraser, R and McCuskey, RS (1980) On the role of the liver endothelial filter in the transport of particulate fat (chylomicrons and their remnants) to parenchymal cells and the influence of certain hormones on the endothelial fenestrae. In: Popper, H, Gudat, F, Bianchi, L and Reutter, W (eds). Communications of Liver Cells, MTP Press: Basel. pp. 195-200.
6. Oda, M, Azuma, T, Watanabe, N, Nishizaku, Y, Nishida, Y, Ischii, K et al. (1990). Regulatory mechanism of hepatic microcirculation: involvement of the contraction and dilatation of sinusoids and sinusoidal endothelial fenestrae. Prog Appl Microcirc 17: 103-128.
7. Braet, F and Wisse, E (2002). Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: A review. Comp Hepatol 1 1-17.
8. Van Rooijen, N and Sanders, A (1994). Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93.
9. Pietras, K, Ostman, A, Sjoquist, M, Buchdunger, E, Reed, RK, Heldin, CH et al. (2001). Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 61: 2929-2934.
10. Buchdunger, E, Cioffi, CL, Law, N, Stover, D, Ohno-Jones, S, Druker, BJ et al. (2000). Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 295: 139-145.
11. Pietras, K, Rubin, K, Sjoblom, T, Buchdunger, E, Sjoquist M, Heldin, CH et al. (2002). Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res 62 5476-5484.
12. Hwang, RF, Yokoi, K, Bucana, CD, Tsan, R, Killion, JJ, Evans, DB et al. (2003). Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clin Cancer Res 9: 6534-6544.
13. Heuchel, R, Berg, A, Tallquist, M, Ahlen, K, Reed, RK, Rubin, K et al. (1999). Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling. Proc Natl Acad Sci USA 96: 11410-11415.
14. Reed, RK, Berg, A, Gjerde, EA and Rubin, K (2001). Control of Interstitial fluid pressure: Role of beta1-integrins. Semin Nephrol 21: 222-230.
15. Shi, W, Bastianutto, C, Li, A, Perez-Ordonez, B, Ng, R, Chow, KY et al. (2006). Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 119: 2467-2475.
16. Contag, CH, Spilman, SD, Contag, PR, Oshiro, M, Eames, B, Dennery, P et al. (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66: 523-531.
17. Kanerva, A, Zinn, KR, Chaudhuri, TR, Lam, JT, Suzuki, K, Uil, TG et al. (2003). Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Mol Ther 8 449-458.
18. Rehemtulla, A, Hall, DE, Stegman, LD, Prasad, U, Chen, G, Bhojani, MS et al. (2002). Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. Mol Imaging 1: 43-55.
19. Sato, M, Johnson, M, Zhang, L, Zhang, B, Le, K, Gambhir, SS et al. (2003). Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy. Mol Ther 8: 726-737.
20. Mocanu, JD, Moriyama, EH, Chia, MC, Li, JH, Yip, KW, Huang, DP et al. (2004). Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy. Mol Imaging 3: 352-355.
21. Lee, KH, Byun, SS, Paik, JY, Lee, SY, Song, SH, Choe, YS et al. (2003). Cell uptake and tissue distribution of radioiodine labelled D-luciferin: Implications for luciferase based gene imaging. Nucl Med Commun 24: 1003-1009.
22. Cheong, WF, Prahl, SA and Welch, AJ (1990). A review of the optical properties of biological tissues. IEEE J Quantum Electron 26 2166-2185.
23. Rice, BW, Cable, MD and Nelson, MB (2D01). In vivo imaging of light-emitting probes. J Biomed Opt 6: 432-440.
24. Langle-Rouault, F, Patzel, V, Benavente, A, Taillez, M, Silvestre, N, Bompard, A et al. (1998). Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: Implications of the nuclear import of plasmids. J Virol 72: 6181-6185.
25. Bilsland, AE, Fletcher-Monaghan, A and Keith, WN (2005). Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapy. Neoplasia 7: 1020-1029.
26. Rein, DT, Breidenbach, M, Nettelbeck, DM, Kawakami, Y, Siegal, GP, Huh, WK et al. (2004). Evaluation of tissue-specific promoters in carcinomas of the cervix uteri. J Gene Med 6: 1281-1289.
27. Liu, Y, Liggitt, D, Zhong, W, Tu, G, Gaensler, K and Debs, R (1995). Cationic liposome-mediated intravenous gene delivery. J Biol Chem 270: 24864-24870.
28. Duncan, SJ, Gordon, FC, Gregory, DW, McPhie, JL, Postlethwaite, R, White, R et al. (1978). Infection of mouse liver by human adenovirus type 5. J Gen Virol 40: 45-61.
29. Shayakhmetov, DM, Gaggar, A, Ni, S, Li, ZY and Lieber, A (2005). Adenovirus binding to blood factors results in liver cell infection and hepatatoxicity. J Virol 79: 7478-7491.
30. Shayakhmetov, DM, Li, ZY, Ni, S and Lieber, A (2004). Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J Virol 78: 5368-5381.
31. Croyle, MA, Chirmule, N, Zhang, Y and Wilson, JM (2001). "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol 75: 4792-4801.
32. Alemany, R, Suzuki, K and Curiel, DT (2000). Blood clearance rates of adenovirus type 5 in mice. J Gen Virol 81: 2605-2609.
33. Nakayama, M, Both, GW, Banizs, 8, Tsuruta, Y, Yamamoto, S, Kawakami, Y et al. (2006). An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice. Virology 350: 103-115.
34. Gatmaitan, Z, Varticovski, L, Ling, L, Mikkelsen, R, Steffan, AM and Arias, IM (1996). Studies on fenestral contraction in rat liver endothelial cells in culture. Am J Pathol 148: 2027-2041.
35. Rothe, CF and Maass-Moreno, R (2000). Active and passive liver microvascular responses from angiotensin, endothelin, norepinephrine, and vasopressin. Am J Physiol Heart Circ Physiol 279: H1147-H1156.
36. Netti, PA, Hamberg, LM, Babich, JW, Kierstead, D, Graham, W, Hunter, GJ et al. (1999). Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules. Proc Natl Acad Sci USA 96: 3137-3142.
37. Lievens, J, Snoeys, J, Vekemans, K, Van Linthout, S, de Zanger, R, Collen, D et al. (2004). The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transfer. Gene Ther 11: 1523-1531.
38. Yu, Q, Que, LG and Rockey, DC (2002). Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver. Am J Physiol Gastrointest Liver Physiol 292: G565-G572.
39. Lieber, A, He, CY, Meuse, L, Schowalter, D, Kirillova, I, Winther, B et al. (1997). The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 71: 8798-8807.
40. Deininger, MW, Goldman, JM, Lydon, N and Melo, JV (1997). The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. Blood 90: 3691-3698.
41. Heinrich, MC, Griffith, DJ, Druker, BJ, Wait, CL, Ott, KA and Zigler, AJ (2000). Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96: 925-932.
42. Wang, WL, Healy, ME, Sattler, M, Verma, S, Lin, J, Maulik, G et al. (2000). Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene 19: 3521-3528.
43. Pietras, K, Stumm, M, Hubert, M, Buchdunger, E, Rubin, K, Heldin, CH et al. (2003). STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake. Clin Cancer Res 9 3779-3787.
44. Baranowska-Kortylewicz, J, Abe, M, Pietras, K, Kortylewicz, ZP, Kurizaki, T Nearman, J et al. (2005). Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy. Cancer Res 65: 7824-7831.
45. Cheung, ST, Huang, DP, Hui, AB, Lo, KW, Ko, CW Tsang, YS et al. (1999). Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 83: 121-126.
46. Busson, P, Ganem, G, Flores, P, Mugneret, F, Clausse, B, Calliou, B et al. (1988). Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42: 599-606.
47. Ng, P, Parks, RJ, Cummings, DT, Evelegh, CM, Sankar, U and Graham, FL (1999). A high-efficiency Cre/loxP-based system for construction of adenoviral vectors. Hum Gene Ther 10: 2667-2672.
48. Hitt, M, Bett, AJ, Prevec, L and Graham, FL (1998). Construction and propagation of human adenovirus vectors. In: Celis, JE (ed.). Cell Biology: A Laboratory Handbook, 2nd edn, vol. 1. Academic Press: San Diego, CA. pp. 500-512.
49. Milosevic, MF, Fyles, AW, Wong, R, Pintille, M, Kavanagh, MC, Levin, W et al. (1998). Interstitial fluid pressure in cervical carcinoma: within tumor heterogeneity, and relation to oxygen tension. Cancer 82: 2418-2426.
50. Heim, A, Ebnet, C, Harste, G and Pring-Akerblom, P (2003). Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 70: 228-239.